{
    "nctId": "NCT01129622",
    "briefTitle": "Effect of Aromatase Inhibitors on Breast Magnetic Resonance Imaging (MRI)",
    "officialTitle": "Phase II Study of the Effect of Acute Aromatase Inhibition on Breast MRI Postmenopausal Women",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 16,
    "primaryOutcomeMeasure": "Number of Women With Reduced Breast Parenchymal Enhancement",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women are eligible to participate if they are 40 years or older and have been menopausal (had no menstrual bleeding during the past 12 months)\n\nExclusion Criteria:\n\n* History of bilateral mastectomy, osteoporosis or renal impairment.",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}